In conclusion, a variety of downstream protein regulatory pathways that collectively make up a systemic regulatory network in CCA cell growth and invasion are linked to energy metabolism through NAMPT/NAD+ and are the potential targets for cancer therapeutics. Here, NAMPT is linked to cholangiocarcinoma.